Ad is loading...
NEFOX
Price
$32.22
Change
-$0.18 (-0.56%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

NEFOX vs VIVIX

Header iconNEFOX vs VIVIX Comparison
Open Charts NEFOX vs VIVIXBanner chart's image
Natixis Oakmark A
Price$32.22
Change-$0.18 (-0.56%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
NEFOX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NEFOX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEFOX is a Sell and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. NEFOX (897M). VIVIX pays higher dividends than NEFOX: VIVIX (2.37) vs NEFOX (0.51). NEFOX was incepted earlier than VIVIX: NEFOX (94 years) vs VIVIX (26 years). NEFOX is a more actively managed with annual turnover of: 40.00 vs. VIVIX (10.00). NEFOX has a lower initial minimum investment than VIVIX: NEFOX (2500) vs VIVIX (5000000). NEFOX (26.37) and VIVIX (25.54) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. NEFOX (44.57).
NEFOXVIVIXNEFOX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence94 years26 years-
Gain YTD18.29417.922102%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets897M184B0%
Annual Yield % from dividends0.512.3721%
Returns for 1 year26.3725.54103%
Returns for 3 years2.7621.5713%
Returns for 5 years44.5750.7988%
Returns for 10 years44.39110.5040%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics